Article Text

Download PDFPDF
PS-079 Implementation of proactive medicines reconciliation to reduce drug errors at admission
  1. S Renet1,
  2. J Raymond1,
  3. P Bravo1,
  4. R Haddad1,
  5. G Bussone2,
  6. B Laquerriere2,
  7. R Fior2,
  8. A Rieutord1,
  9. N Curatolo1
  1. 1AP-HP – Hôpital Antoine Béclère HUPS, Service Pharmacie, Clamart, France
  2. 2AP-HP – Hôpital Antoine Béclère HUPS, Service Médecine Interne, Clamart, France


Background Medicines reconciliation (MR) is a critical step for reducing medicines errors (ME) at admission to hospital care. However, because of resource constraints it can be difficult to implement in hospital pharmacists’ everyday practice. The Lean method is used to streamline and optimise processes considering all stakeholders and resources.

Purpose To redesign the medicines management process at admission to reduce MEs.

Material and methods A Lean approach review was conducted of the current medicines management process at admission (retroactive MR process) in order to define the new process (proactive MR), with all the stakeholders (clinicians, nurses, pharmacists, pharmacy technicians, head nurses). 5 activities were performed:

  • mapping of the current process (retroactive MR process)

  • measure of unintended medicines discrepancies (UMDs) at admission

  • analysis of the collected data and root cause implementation

  • design of a new improved process (proactive MR)

  • implementation and measurement of the new process

Only patients more than 65 years old and/or taking at least 3 medicines before admission were included.

Results 52 patients were initially included (75 years, 7.4 medicines/patient). 46% had at least 1 UMD (0.75 UMDs/patient) and 28.2% of UMDs had the potential to cause moderate to severe discomfort or clinical deterioration. After implementation of the new MR process, 50 patients were included (70 years, 6.9 medicines/patient). The percentage of patients with at least 1 UMD decreased to 12% (p < 0.01) (0.16 UMDs/patient) and 28.6% of UMDs had the potential to cause moderate to severe discomfort or clinical deterioration.

Conclusion Results demonstrate that proactive MR is effective in reducing ME on admissions orders and suggest that Lean is fully adapted to improve the medicines management process. Other studies are warranted to evaluate the impact of Lean on ME reduction.

References and/or acknowledgements No conflict of interest.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.